Eckert & Ziegler AG O.N. (EUZG)

Currency in EUR
15.020
-0.240(-1.57%)
Closed·
Earnings results expected in 8 days
EUZG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.99015.420
52 wk Range
13.30023.250
Key Statistics
Bid/Ask
14.95 / 15.02
Prev. Close
15.26
Open
15.24
Day's Range
14.99-15.42
52 wk Range
13.3-23.25
Volume
79.06K
Average Volume (3m)
117.04K
1-Year Change
-25.3355%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EUZG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.433
Upside
+49.36%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Eckert & Ziegler AG O.N. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 22.433
(+49.36% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Kepler Cheuvreux
Buy20.30+35.15%21.70Maintain27/03/2026

Earnings

Latest Release
26/03/2026
EPS / Forecast
0.30 / --
Revenue / Forecast
87.84M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.78%
Dividend Yield
1.09%
Industry Median 1.99%
Annualised payout
0.17
Paid annually
5-Years Growth
+7.96%
Growth Streak

Compare EUZG to Peers and Sector

Metrics to compare
EUZG
Peers
Sector
Relationship
P/E Ratio
19.6x19.2x−0.5x
PEG Ratio
0.420.660.00
Price/Book
3.8x2.9x2.6x
Price / LTM Sales
3.1x1.3x3.3x
Upside (Analyst Target)
50.7%29.8%47.7%
Fair Value Upside
Unlock6.3%6.6%Unlock

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.

Employees
1116
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
13.19M21.07%201.23M
Other Institutional Investors
23.49M37.54%358.42M
Public Companies & Retail Investors
25.90M41.39%395.23M
Total
62.57M100.00%954.88M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Eckert Wagniskapital und Frühphasenfinanzierung GmbH31.63%19,790,040301,996
JP Morgan Asset Management3.06%1,914,86729,221

People Also Watch

77.900
AOFG
-1.64%
37.520
SAXG
+0.97%
37.060
TPEG
+1.37%
81.950
HYQGn
+0.06%

FAQ

What Is the Eckert&Ziegler AG (Xetra: EUZG) Share Price Today?

The Eckert&Ziegler AG stock price today is 15.020 EUR.

What Stock Exchange Does Eckert&Ziegler AG (EUZG) Trade On?

Eckert&Ziegler AG is listed and trades on the Frankfurt Stock Exchange.

What Is the Ticker (Stock Symbol) for Eckert&Ziegler AG?

The stock symbol (also called a 'ticker') for Eckert&Ziegler AG is "EUZG."

Does Eckert&Ziegler AG Pay Dividends? What’s The Current EUZG Dividend Yield?

Yes, EUZG Pays Dividends to its Shareholders. The current Eckert&Ziegler AG dividend yield is 1.11%.

What Is the Current Eckert&Ziegler AG Market Capitalisation?

As of today, Eckert&Ziegler AG (Xetra: EUZG) market cap is 937.980M EUR.

What Is Eckert&Ziegler AG's (EUZG) Earnings Per Share (TTM)?

The Eckert&Ziegler AG EPS is currently 0.779 (Trailing Twelve Months).

When Is the Next Eckert&Ziegler AG Earnings Date?

Eckert&Ziegler AG's next earnings report will be released on 12/05/2026.

Is EUZG a Buy or Sell From a Technical Analyst Perspective?

Based on today's Eckert&Ziegler AG moving averages and other technical indicators, the daily buy/sell signal for EUZG stock is Strong Buy.

How Many Times Has Eckert&Ziegler AG Stock Split?

Eckert&Ziegler AG has split 4 times. (See the EUZG stock split history page for full effective split date and price information.)

How Many Employees Does Eckert&Ziegler AG Have?

Eckert&Ziegler AG has 1116 employees, based on their latest Companies House report.

What is the current trading status of Eckert&Ziegler AG (Xetra: EUZG)?

As of 04/05/2026, Eckert&Ziegler AG (EUZG) is trading at a share price of 15.020 EUR, with a previous close of 15.260 EUR. The stock has fluctuated within a day range of 14.990 EUR to 15.420 EUR, while its 52-week range spans from 13.300 EUR to 23.250 EUR.

What Is Eckert&Ziegler AG (EUZG) Price Target According to Analysts?

The average 12-month price target for Eckert&Ziegler AG is 22.433 EUR, with a high estimate of 24 EUR and a low estimate of 20.3 EUR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +49.36% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.